{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:17:39Z","timestamp":1791231459035,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T00:00:00Z","timestamp":1240444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T00:00:00Z","timestamp":1240444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/leu.2009.93","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T05:45:04Z","timestamp":1240465504000},"page":"1106-1117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Flow cytometric immunobead assay for the detection of BCR\u2013ABL fusion proteins in leukemia patients"],"prefix":"10.1038","volume":"23","author":[{"given":"F","family":"Weerkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Dekking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Y","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V H J","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"van der Sluijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Boeckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Van Poecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lucio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Szczepa\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Flores-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lhermitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K A J","family":"Brouwer-De Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Noordijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W M","family":"Comans-Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J T","family":"Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J M","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,23]]},"reference":[{"key":"BFleu200993_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc2091","volume":"7","author":"F Mitelman","year":"2007","unstructured":"Mitelman F, Johansson B, Mertens F . The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7: 233\u2013245.","journal-title":"Nat Rev Cancer"},{"key":"BFleu200993_CR2","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood-2008-04-097931","volume":"112","author":"JD Rowley","year":"2008","unstructured":"Rowley JD . Chromosomal translocations: revisited yet again. Blood 2008; 112: 2183\u20132189.","journal-title":"Blood"},{"key":"BFleu200993_CR3","first-page":"1497","volume":"132","author":"P Nowell","year":"1960","unstructured":"Nowell P, Hungerford D . A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497.","journal-title":"Science"},{"key":"BFleu200993_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD . A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290\u2013293.","journal-title":"Nature"},{"key":"BFleu200993_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/300765a0","volume":"300","author":"A de Klein","year":"1982","unstructured":"de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982; 300: 765\u2013767.","journal-title":"Nature"},{"key":"BFleu200993_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/306277a0","volume":"306","author":"CR Bartram","year":"1983","unstructured":"Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D et al. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983; 306: 277\u2013280.","journal-title":"Nature"},{"key":"BFleu200993_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G . Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93\u201399.","journal-title":"Cell"},{"key":"BFleu200993_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","volume":"37","author":"JB Konopka","year":"1984","unstructured":"Konopka JB, Watanabe SM, Witte ON . An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035\u20131042.","journal-title":"Cell"},{"key":"BFleu200993_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y Ben-Neriah","year":"1986","unstructured":"Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D . The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene. Science 1986; 233: 212\u2013214.","journal-title":"Science"},{"key":"BFleu200993_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0092-8674(87)90007-9","volume":"51","author":"A Hermans","year":"1987","unstructured":"Hermans A, Heisterkamp N, von Linden M, van Baal S, Meijer D, van der Plas D et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987; 51: 33\u201340.","journal-title":"Cell"},{"key":"BFleu200993_CR11","unstructured":"Hermans A, Gow J, Selleri L, von Lindern M, Hagemeijer A, Wiedemann LM et al. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. 1988; 2: 628\u2013633."},{"key":"BFleu200993_CR12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","volume":"88","author":"F Pane","year":"1996","unstructured":"Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction). Blood 1996; 88: 2410\u20132414.","journal-title":"Blood"},{"key":"BFleu200993_CR13","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","volume":"88","author":"JV Melo","year":"1996","unstructured":"Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375\u20132384.","journal-title":"Blood"},{"key":"BFleu200993_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1182\/blood.V99.5.1536","volume":"99","author":"B Gleissner","year":"2002","unstructured":"Gleissner B, Gokbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 2002; 99: 1536\u20131543.","journal-title":"Blood"},{"key":"BFleu200993_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1046\/j.1365-2141.1998.01098.x","volume":"103","author":"C Haskovec","year":"1998","unstructured":"Haskovec C, Ponzetto C, Polak J, Maritano D, Zemanova Z, Serra A et al. P230 BCR\/ABL protein may be associated with an acute leukaemia phenotype. Br J Haematol 1998; 103: 1104\u20131108.","journal-title":"Br J Haematol"},{"key":"BFleu200993_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/sj.leu.2403761","volume":"19","author":"N Boeckx","year":"2005","unstructured":"Boeckx N, Jansen MW, Haskovec C, Vandenberghe P, van der Velden VH, van Dongen JJ . Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR. Leukemia 2005; 19: 1292\u20131295.","journal-title":"Leukemia"},{"key":"BFleu200993_CR17","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood.V88.6.2236.bloodjournal8862236","volume":"88","author":"A Hochhaus","year":"1996","unstructured":"Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U et al. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood 1996; 88: 2236\u20132240.","journal-title":"Blood"},{"key":"BFleu200993_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/sj.leu.2403604","volume":"19","author":"S Demehri","year":"2005","unstructured":"Demehri S, Paschka P, Schultheis B, Lange T, Koizumi T, Sugimoto T et al. e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants? Leukemia 2005; 19: 681\u2013684.","journal-title":"Leukemia"},{"key":"BFleu200993_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.leu.2404580","volume":"21","author":"VH van der Velden","year":"2007","unstructured":"van der Velden VH, Beverloo HB, Hoogeveen PG, Zwaan Ch M . A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia. Leukemia 2007; 21: 833\u2013835.","journal-title":"Leukemia"},{"key":"BFleu200993_CR20","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia. Blood 2000; 96: 3343\u20133356.","journal-title":"Blood"},{"key":"BFleu200993_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00062752-200301000-00007","volume":"10","author":"E Anastasiadou","year":"2003","unstructured":"Anastasiadou E, Schwaller J . Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an update. Curr Opin Hematol 2003; 10: 40\u201348.","journal-title":"Curr Opin Hematol"},{"key":"BFleu200993_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031\u20131037.","journal-title":"N Engl J Med"},{"key":"BFleu200993_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1056\/NEJMct071828","volume":"357","author":"CA Schiffer","year":"2007","unstructured":"Schiffer CA . BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med 2007; 357: 258\u2013265.","journal-title":"N Engl J Med"},{"key":"BFleu200993_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc2126","volume":"7","author":"E Weisberg","year":"2007","unstructured":"Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD . Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 2007; 7: 345\u2013356.","journal-title":"Nat Rev Cancer"},{"key":"BFleu200993_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/sj.leu.2403340","volume":"18","author":"M Van der Burg","year":"2004","unstructured":"Van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004; 18: 895\u2013908.","journal-title":"Leukemia"},{"key":"BFleu200993_CR26","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJM Van Dongen","year":"1999","unstructured":"Van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901\u20131928.","journal-title":"Leukemia"},{"key":"BFleu200993_CR27","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, Van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"},{"key":"BFleu200993_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1084\/jem.169.1.87","volume":"169","author":"J Van Denderen","year":"1989","unstructured":"Van Denderen J, Hermans A, Meeuwsen T, Troelstra C, Zegers N, Boersma W et al. Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia. J Exp Med 1989; 169: 87\u201398.","journal-title":"J Exp Med"},{"key":"BFleu200993_CR29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.V76.1.136.136","volume":"76","author":"J van Denderen","year":"1990","unstructured":"van Denderen J, van der Plas D, Meeuwsen T, Zegers N, Boersma W, Grosveld G et al. Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1990; 76: 136\u2013141.","journal-title":"Blood"},{"key":"BFleu200993_CR30","first-page":"1107","volume":"6","author":"J van Denderen","year":"1992","unstructured":"van Denderen J, ten Hacken P, Berendes P, Zegers N, Boersma W, Grosveld G et al. Antibody recognition of the tumor-specific b3-a2 junction of bcr-abl chimeric proteins in Philadelphia-chromosome-positive leukemias. Leukemia 1992; 6: 1107\u20131112.","journal-title":"Leukemia"},{"key":"BFleu200993_CR31","first-page":"1503","volume":"8","author":"J van Denderen","year":"1994","unstructured":"van Denderen J, ten Hacken P, Berendes P, Zegers N, Boersma W, Grosveld G et al. Recognition of the ALL-specific BCR-ABL junction in P190bcr-abl by monoclonal antibody ER-FP1. Leukemia 1994; 8: 1503\u20131509.","journal-title":"Leukemia"},{"key":"BFleu200993_CR32","unstructured":"Berendes PB, Veenman JN, Van Denderen AC, Van Ewijk W . Recognition of tumor-specific gene products in cancer (Fusion protein dipstick patent). International Patent 1998, (PCT\/NL98\/00289)."},{"key":"BFleu200993_CR33","first-page":"111","volume-title":"Recognition of Tumor-Specific Proteins in Human Cancer","author":"PB Berendes","year":"1997","unstructured":"Berendes PB, Veenman JN, Van Denderen AC, Van Ewijk W . The BCR-ABL dipstick assay: a simple and rapid method for detecting Ph+ leukemias. In: Berendes P (ed). Recognition of Tumor-Specific Proteins in Human Cancer. PhD Thesis. Department of Immunology, Erasmus University Rotterdam: Rotterdam, The Netherlands, 1997, pp 111\u2013127."},{"key":"BFleu200993_CR34","unstructured":"Van Dongen JJM, Van der Velden VHJ, Berendes PB, Van Denderen AC . Recognition of tumour-specific gene products in cancer (Fusion protein bead patent). International Patent 2001, (PCT\/NL01\/00.945)."},{"key":"BFleu200993_CR35","first-page":"3192","volume":"55","author":"H Wada","year":"1995","unstructured":"Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai M et al. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR\/ABL fusion protein. Cancer Res 1995; 55: 3192\u20133196.","journal-title":"Cancer Res"},{"key":"BFleu200993_CR36","first-page":"3048","volume":"51","author":"JQ Guo","year":"1991","unstructured":"Guo JQ, Wang JY, Arlinghaus RB . Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients. Cancer Res 1991; 51: 3048\u20133051.","journal-title":"Cancer Res"},{"key":"BFleu200993_CR37","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program. Leukemia 2003; 17: 2474\u20132486.","journal-title":"Leukemia"},{"key":"BFleu200993_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui CH, Robison LL, Look AT . Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030\u20131043.","journal-title":"Lancet"},{"key":"BFleu200993_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2796.2005.01476.x","volume":"257","author":"O Wiedow","year":"2005","unstructured":"Wiedow O, Meyer-Hoffert U . Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 2005; 257: 319\u2013328.","journal-title":"J Intern Med"},{"key":"BFleu200993_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.cdd.4401320","volume":"11","author":"NA Maianski","year":"2004","unstructured":"Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D, Kuijpers TW . Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ 2004; 11: 143\u2013153.","journal-title":"Cell Death Differ"},{"key":"BFleu200993_CR41","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1128\/MCB.11.3.1553","volume":"11","author":"JR McWhirter","year":"1991","unstructured":"McWhirter JR, Wang JY . Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr\/abl fusion proteins. Mol Cell Biol 1991; 11: 1553\u20131565.","journal-title":"Mol Cell Biol"},{"key":"BFleu200993_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000065655","volume":"108","author":"DJ Barnes","year":"2002","unstructured":"Barnes DJ, Melo JV . Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia. Acta Haematol 2002; 108: 180\u2013202.","journal-title":"Acta Haematol"},{"key":"BFleu200993_CR43","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1365-2141.2005.05944.x","volume":"132","author":"D Primo","year":"2006","unstructured":"Primo D, Sanchez ML, Espinosa AB, Tabernero MD, Rasillo A, Sayagues JM et al. Lineage involvement in chronic myeloid leukaemia: comparison between MBCR\/ABL and mBCR\/ABL cases. Br J Haematol 2006; 132: 736\u2013739.","journal-title":"Br J Haematol"},{"key":"BFleu200993_CR44","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.leu.2404189","volume":"20","author":"A Hamilton","year":"2006","unstructured":"Hamilton A, Elrick L, Myssina S, Copland M, Jorgensen H, Melo JV et al. BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry. Leukemia 2006; 20: 1035\u20131039.","journal-title":"Leukemia"},{"key":"BFleu200993_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","volume":"2","author":"T Szczepa\u00f1ski","year":"2001","unstructured":"Szczepa\u00f1ski T, Orfao A, van der Velden VHJ, San Miguel JF, van Dongen JJM . Minimal residual disease in leukaemia patients. Lancet Oncol 2001; 2: 409\u2013417.","journal-title":"Lancet Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200993","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:02:49Z","timestamp":1648720969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,23]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFleu200993"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.93","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,23]]},"assertion":[{"value":"19 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}